Suchergebnisse - "Musa, Fernanda"
-
1
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
ISSN: 0028-4793, 1533-4406, 1533-4406Veröffentlicht: United States Massachusetts Medical Society 08.06.2023Veröffentlicht in The New England journal of medicine (08.06.2023)“… In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer …”
Volltext
Journal Article -
2
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025
ISSN: 1473-656X, 1473-656XVeröffentlicht: England 01.04.2025Veröffentlicht in Current opinion in obstetrics & gynecology (01.04.2025)“… Endometrial cancer (EC) is rising in incidence, particularly in younger, premenopausal women, due to increasing rates of obesity and delayed childbearing. This …”
Weitere Angaben
Journal Article -
3
Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer
ISSN: 0090-8258, 1095-6859, 1095-6859Veröffentlicht: United States Elsevier Inc 01.03.2022Veröffentlicht in Gynecologic oncology (01.03.2022)“… Current treatments for recurrent or metastatic cervical cancer (r/mCC) do not offer satisfactory clinical benefits, with most patients progressing beyond …”
Volltext
Journal Article -
4
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
ISSN: 1546-170X, 1546-170XVeröffentlicht: United States 01.05.2025Veröffentlicht in Nature medicine (01.05.2025)“… Historically, the treatment of patients with advanced stage or recurrent endometrial cancer included paclitaxel plus carboplatin. Immunotherapy in combination …”
Weitere Angaben
Journal Article -
5
Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 18.07.2024Veröffentlicht in PloS one (18.07.2024)“… Despite advances in cervical cancer (CC) prevention, detection, and treatment in the US, health disparities persist, disproportionately affecting underserved …”
Volltext
Journal Article -
6
Ivermectin and Gynecologic Cancer: What are the data?
ISSN: 2352-5789, 2352-5789Veröffentlicht: Elsevier Inc 01.08.2025Veröffentlicht in Gynecologic oncology reports (01.08.2025)“… •Ivermectin is currently approved by the US Food and Drug Administration (FDA) in 1996 as an oral medication for intestinal strongyloidiasis and …”
Volltext
Journal Article -
7
Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 20.05.2025Veröffentlicht in PloS one (20.05.2025)“… [This corrects the article DOI: 10.1371/journal.pone.0307282.] …”
Volltext
Journal Article -
8
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
ISSN: 0028-4793, 1533-4406Veröffentlicht: 08.06.2023Veröffentlicht in The New England journal of medicine (08.06.2023)Volltext
Journal Article -
9
Patterns of genomic testing for epithelial ovarian cancer across a large community-based health care network: A real world experience (596)
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.08.2022Veröffentlicht in Gynecologic oncology (01.08.2022)“… Objectives: NCCN guidelines recommend germline and somatic tumor testing, including homologous recommendation deficiency, for all women with invasive …”
Volltext
Journal Article -
10
Frequency of homologous recombination deficiency in a large community-based cohort of epithelial ovarian cancer cases (597)
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.08.2022Veröffentlicht in Gynecologic oncology (01.08.2022)“… Objectives: Homologous recombination deficiency (HRD) is a useful predictor of treatment response in patients with epithelial ovarian cancer (EOC). Reported …”
Volltext
Journal Article -
11
Factors impacting genomic testing rates among epithelial ovarian cancer patients across a large community-based healthcare system (595)
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.08.2022Veröffentlicht in Gynecologic oncology (01.08.2022)“… Objectives: To determine the rates of germline and somatic testing for epithelial ovarian cancer (EOC) patients and identify factors that impact testing rates …”
Volltext
Journal Article -
12
Patient-reported experiences with telemedicine: ask first
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.08.2021Veröffentlicht in Gynecologic oncology (01.08.2021)“… To assess patient experiences with the use of a telemedicine program initiated in response to the COVID-19 pandemic and identify factors associated with …”
Volltext
Journal Article -
13
The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology
ISSN: 2352-5789, 2352-5789Veröffentlicht: Netherlands Elsevier Inc 01.10.2024Veröffentlicht in Gynecologic oncology reports (01.10.2024)“… •Physicians provided higher quality responses to common clinical questions in gynecologic oncology compared to chatbots.•Chatbots provided longer, more …”
Volltext
Journal Article -
14
Mucinous histology is a risk factor for nodal metastases in endometrial cancer
ISSN: 0090-8258, 1095-6859, 1095-6859Veröffentlicht: United States Elsevier Inc 01.06.2012Veröffentlicht in Gynecologic oncology (01.06.2012)“… Mucinous adenocarcinoma of the endometrium (MUC) is a rare histological variant of endometrial carcinoma accounting for 1–9% of endometrioid tumors. Few …”
Volltext
Journal Article -
15
Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?
ISSN: 0002-9378, 1097-6868, 1097-6868Veröffentlicht: New York, NY Mosby, Inc 01.11.2012Veröffentlicht in American journal of obstetrics and gynecology (01.11.2012)“… We sought to determine the prevalence of adenomyosis and assess its effect on lymph node status in endometrioid adenocarcinoma of the endometrium (EAC) …”
Volltext
Journal Article Tagungsbericht -
16
Cross-Sectional Study of the Impact of a Natural Disaster on the Delivery of Gynecologic Oncology Care
ISSN: 1935-7893, 1938-744XVeröffentlicht: New York, USA Cambridge University Press 01.12.2015Veröffentlicht in Disaster medicine and public health preparedness (01.12.2015)“… We aimed to compare access to gynecologic oncology care at a private and a city hospital, both of which closed for a period of time because of Hurricane Sandy …”
Volltext
Journal Article -
17
Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations
ISSN: 1873-233X, 1873-233XVeröffentlicht: United States 01.04.2020Veröffentlicht in Obstetrics and gynecology (New York. 1953) (01.04.2020)“… This publication represents an extensive literature review with the goal of providing guidelines for the evaluation and management of cervical adenocarcinoma …”
Weitere Angaben
Journal Article -
18
Postoperative bowel herniation in a 5-mm nonbladed trocar site
ISSN: 1086-8089Veröffentlicht: United States 01.04.2010Veröffentlicht in Journal of the Society of Laparoendoscopic Surgeons (01.04.2010)“… Incisional hernias are a rare complication of laparoscopic surgery, with a reported incidence of <1%. We describe a case of bowel herniation and strangulation …”
Weitere Angaben
Journal Article -
19
Adherence to risk-reducing bilateral salpingo-oophorectomy in carriers of a BRCA pathogenic variant
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.09.2025Veröffentlicht in Gynecologic oncology (01.09.2025)Volltext
Journal Article -
20
Real-world adherence to guideline-based therapy in early-stage mucinous ovarian cancer
ISSN: 0090-8258Veröffentlicht: Elsevier Inc 01.09.2025Veröffentlicht in Gynecologic oncology (01.09.2025)Volltext
Journal Article